|
Volumn 138, Issue 5, 2001, Pages 699-704
|
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CIPROFLOXACIN;
DORNASE ALFA;
TIMENTIN;
TOBRAMYCIN;
ARTICLE;
CHILD;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DISEASE SEVERITY;
FEMALE;
FORCED EXPIRATORY VOLUME;
GRAM NEGATIVE INFECTION;
HUMAN;
LUNG LAVAGE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
SPIROMETRY;
SPUTUM CULTURE;
TREATMENT OUTCOME;
|
EID: 0035002870
PISSN: 00223476
EISSN: None
Source Type: Journal
DOI: 10.1067/mpd.2001.112897 Document Type: Article |
Times cited : (374)
|
References (25)
|